Egg Donation: A Victory for Reproductive Justice or Another Handmaid’s Tale?
By Chantal Bittner,
Bill of Health
| 02. 04. 2025
Before the United States election in 2024, Margaret Atwood shared a cartoon illustrating the handmaids from her dystopian novel entering a polling booth in their unmistakable red cloaks and white bonnets. Having voted, they transform into unique individuals, discarding the attire symbolizing their reproductive enslavement.
One of the central topics of the election campaign was undoubtedly abortion—a key issue in the fight for reproductive justice. However, reproductive justice encompasses far more than abortion. The egg donation industry has expanded into a multi-billion dollar market. While altruism frequently frames their actions, financial incentives are central to attracting many young women to donate—really, sell—their eggs. Upon closer examination, egg donors play a subordinate role despite being essential for the market to function. This post explores the egg market in the U.S. and Europe, shedding light on its implications for the reproductive rights of third parties involved in the process.
The U.S.: A free market model
In the U.S., egg donation operates as an unregulated free market. Compensation varies widely, reaching up to $250,000 in exceptional cases, with an average payment of approximately $7,000. Efforts by the American Society for Reproductive Medicine (ASRM) to regulate this market through guidelines capping payments failed: ASRM attempted to limit donor remuneration to $10,000. However, two donors sued ASRM, claiming the guidelines violated U.S. antitrust laws by constituting price-fixing. In 2015...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Elise Kinsella, ABC News | 06.15.2025
When *Sarah and her partner needed fertility testing, it was Monash IVF that the pair turned to.
"Having a quick browse online, Monash IVF was one of the most prominent ones that came up on Google search and after contacting...
By Tory Shepherd, The Guardian | 06.13.2025
IVF is “big business” and experts are concerned about conflicts of interest between profit-making and helping families have children.
Monash IVF’s second embryo bungle has sparked renewed scrutiny on the IVF industry as a whole amid calls for national regulation...